Moody National Bank Trust Division’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $786K | Sell |
1,498
-53
| -3% | -$27.8K | 0.07% | 285 |
|
|
2025
Q1 | $984K | Buy |
1,551
+53
| +4% | +$33.6K | 0.1% | 231 |
|
|
2024
Q4 | $1.07M | Buy |
+1,498
| New | +$1.07M | 0.11% | 220 |
|
|
2023
Q4 | – | Sell |
-1,146
| Closed | -$943K | – | 619 |
|
|
2023
Q3 | $943K | Buy |
1,146
+16
| +1% | +$13.2K | 0.06% | 232 |
|
|
2023
Q2 | $812K | Hold |
1,130
| – | – | 0.06% | 262 |
|
|
2023
Q1 | $928K | Hold |
1,130
| – | – | 0.08% | 222 |
|
|
2022
Q4 | $816K | Hold |
1,130
| – | – | 0.07% | 230 |
|
|
2022
Q3 | $778K | Buy |
1,130
+16
| +1% | +$11K | 0.08% | 225 |
|
|
2022
Q2 | $659K | Buy |
+1,114
| New | +$659K | 0.07% | 239 |
|
|
2019
Q2 | – | Sell |
-67
| Closed | -$28K | – | 832 |
|
|
2019
Q1 | $28K | Buy |
67
+11
| +20% | +$4.6K | ﹤0.01% | 489 |
|
|
2018
Q4 | $21K | Buy |
+56
| New | +$21K | ﹤0.01% | 465 |
|